In one of the largest civil settlements in U.S. history, Merck & Co., the New Jersey-based manufacturer of the anti-inflammatory drug Vioxx, recently agreed to pay $4.85 billion to end various Vioxx-related claims in which plaintiffs suffered a heart attack, sudden cardiac death, or stroke. 
Read More Merck to Pay $4.85 Billion in Landmark Pharmaceutical Settlement

In the wake of a Nevada jury’s recent  $99 million punitive damages judgment against Wyeth Pharmaceuticals Inc., in L. Brocklin v. Wyeth, No. CV04-01701 (October, 15, 2007), Wyeth’s attorneys are vowing to appeal what they are calling an “aberration” in the various hormone replacement cases brought against the Madison, N.J.-based company. 


Read More Wyeth Vows To Appeal $99 Million Punitive Damages “Aberration” In Nevada Hormone Replacement Case

The United States Court of Appeals for the First Circuit recently held that, where a design is beyond the common experience or knowledge of the average layperson, a defective or negligent design case cannot succeed unless the plaintiff presents evidence “as to the relevant standard of care for the design and the way(s) in which the defendant’s design fell below that standard.” 


Read More First Circuit: Under Puerto Rico Law, A Plaintiff Must Ordinarily Introduce Expert Testimony Concerning Standard Of Care To Prevail On Defective Or Negligent Design Claim

Following a Rhode Island jury’s verdict in 2006 that three manufacturers of lead paint created a public nuisance when they manufactured and sold the paint, the state’s Attorney General, Patrick C. Lynch, has filed a plan to abate lead in houses and buildings in Rhode Island. 


Read More Rhode Island Proposes That Paint Makers Fund a $2.4 Billion Lead Abatement Plan

Christopher Christie, U.S. Attorney for the District of New Jersey, yesterday announced a settlement with four major hip and knee replacement manufacturers that allows the companies to avoid criminal prosecution and civil suits arising from alleged kickback relationships with orthopedic surgeons. 


Read More Hip And Knee Replacement Manufacturers Agree To Pay $310 Million To Avoid Criminal Prosecution And Civil Suits For Alleged Kickback Arrangements With Doctors

As previously reported here, the Supreme Court of Appeals of West Virginia has specifically declined to adopt the learned intermediary doctrine.  Johnson & Johnson Corp. v. Karl, No. 33211 (W.Va. June 27, 2007).  The Court reasoned that the healthcare industry has changed and that pharmaceutical manufacturers “are pushing their products onto the public like never before.” 


Read More West Virginia’s Recent Rejection of The Learned Intermediary Doctrine In The Pharmaceutical Context May Apply Equally To Medical Device Claims

A widely used over-the-counter laxative product is one of the latest targets in nationwide medical product liability litigation.  According to complaints filed in over 50 lawsuits in at least 20 jurisdictions, C.B. Fleet Company’s Phospho-soda product, used commonly to prepare patients for colonoscopies and surgical procedures, has allegedly caused kidney failure and even death in some cases. 


Read More More Than 50 Lawsuits Filed Alleging That Popular Laxative Causes Kidney Failure